Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors.
about
Tissue biomarkers of breast cancer and their association with conventional pathologic features.Proteomics of breast cancer: principles and potential clinical applications.Clinical proteomics and mass spectrometry profiling for cancer detection.Building the power house: recent advances in mitochondrial studies through proteomics and systems biology.Protein profiling of human breast tumor cells identifies novel biomarkers associated with molecular subtypes.Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression.Integrated multi-level quality control for proteomic profiling studies using mass spectrometry.Haptoglobin phenotype is not a predictor of recurrence free survival in high-risk primary breast cancer patients.Proteomics Discovery of Disease Biomarkers.Current status of the prognostic molecular biomarkers in breast cancer: A systematic reviewBreast cancer proteomics: a review for clinicians.Clinical proteomics of breast cancerValidation of tumor-associated macrophage ferritin light chain as a prognostic biomarker in node-negative breast cancer tumors: A multicentric 2004 national PHRC study.Postoperative serum proteomic profiles may predict recurrence-free survival in high-risk primary breast cancer.Identification of potential markers related to neoadjuvant chemotherapy sensitivity of breast cancer by SELDI-TOF MS.Proteomic studies in breast cancer (Review).Proteomic technology for biomarker profiling in cancer: an updateProtein biomarkers for the early detection of breast cancer.Transcriptomic landscape of breast cancers through mRNA sequencing.Breast tumor metastasis: analysis via proteomic profiling.Proteomic serum profile of fatigued men receiving localized external beam radiation therapy for non-metastatic prostate cancerState of the art in tumor antigen and biomarker discovery.Clinical proteomics and breast cancer: strategies for diagnostic and therapeutic biomarker discovery.Validation of UBE2C protein as a prognostic marker in node-positive breast cancer.Breast cancer biomarkers: proteomic discovery and translation to clinically relevant assays.Proteomic analysis of tissue samples in translational breast cancer research.SELDI-TOF proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression.Disulfide-masked iron prochelators: Effects on cell death, proliferation, and hemoglobin production.Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells
P2860
Q31110635-DC6F5314-275A-4FD3-A91B-4FA1265E7B33Q33245053-AA95E2E8-02BD-4BFF-9D67-54B44305131AQ33246668-75FF32CC-D413-4977-A3C3-F5EABE066999Q33252676-B0ACB19D-B28A-48BC-A3DB-18CB02040DB2Q33329750-046D07F5-B360-46A2-8B95-BB7FD77FA070Q33338626-5A871AAA-04B4-47E9-8F70-7236EDA46737Q33389590-29702B81-B557-46E9-8AF0-ADA4BDBE506CQ33395871-B3D65A70-9819-4CD1-9913-438C198D0447Q33478412-DEFC447B-3C50-48C8-B0E7-7157D048EA6FQ33598494-E9709BCE-80C3-4E19-BA1A-3A376FA4A9EDQ33862872-70341187-C734-4628-8ED2-D84E38D11D27Q33885885-294FBF12-8EF5-4838-A23B-BC48781293BEQ34013059-F5F822BD-67A1-43ED-B120-75B165E9FAFDQ34018095-78C7A1A1-EA56-409D-B999-E86DE8049BE5Q34086346-7B1E51E9-B650-45D8-9E99-8E588FF39716Q34319634-C7531594-A3F9-4F76-B112-F0C5590BC24AQ34657835-BA6EC835-E8E4-4922-BE50-49FFBF72AAD9Q35367572-0A6B5E6E-0583-4C1F-BFCB-E4A288C59E50Q35755270-BD86A474-14D7-4514-875C-232EFC57CAABQ36146166-50B40579-2ED0-4AE6-968D-FE93A14F4F80Q37094396-FA95160D-98B9-4F63-B030-FEF582F56C0EQ37132800-398996DB-C7E3-4824-B114-CF4C7BE75E4DQ37137019-0CD75C79-A961-4114-9C82-62FB789B2B60Q37269659-8D7F907C-958B-493E-9D91-17062B1A8910Q38068925-36087B18-2136-4857-9CF5-E56ECA1C7694Q38212502-C6FFBEFF-17A0-4C62-8901-02505F3BA128Q42403162-B0AA7604-C71B-44B4-9E26-4A5EFF103877Q48541625-FF4162C7-CFF3-4F02-AC26-D290B79A49C9Q56974269-6100BEC3-3627-41B3-AB50-F7FEABC67371
P2860
Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Surface-enhanced laser desorpt ...... negative breast cancer tumors.
@ast
Surface-enhanced laser desorpt ...... negative breast cancer tumors.
@en
type
label
Surface-enhanced laser desorpt ...... negative breast cancer tumors.
@ast
Surface-enhanced laser desorpt ...... negative breast cancer tumors.
@en
prefLabel
Surface-enhanced laser desorpt ...... negative breast cancer tumors.
@ast
Surface-enhanced laser desorpt ...... negative breast cancer tumors.
@en
P2093
P50
P356
P1433
P1476
Surface-enhanced laser desorpt ...... negative breast cancer tumors.
@en
P2093
Catherine Charbonnel
Gabriel Ricolleau
Laurence Lodé
Marie-Pierre Joalland
Mario Campone
Ralf Bogumil
Régine Déporte-Fety
Sabine Jourdain
Stéphane Minvielle
P2860
P304
P356
10.1002/PMIC.200500283
P577
2006-03-01T00:00:00Z